Literature DB >> 26563116

Sevelamer crystals in the mucosa of the gastrointestinal tract in a teenager with end-stage renal disease.

Joseph Kim1, Kristin Olson1, Lavjay Butani2.   

Abstract

BACKGROUND: Non-calcium-containing phosphate binders, such as sevelamer preparations, are being increasingly used in patients on dialysis due to their lower association with hypercalcemia and cardiovascular morbidity and mortality. While minor gastrointestinal side effects are quite common with the use of sevelamer, more serious gastrointestinal toxicities have only rarely been reported. CASE-DIAGNOSIS/TREATMENT: We report a pediatric patient on maintenance dialysis receiving sevelamer hydrochloride who developed severe abdominal pain and a high-grade stricture of the sigmoid colon. The patient underwent exploratory laparotomy, resulting in a partial colectomy and colostomy. Histopathologic examination showed colonic mucosal injury and characteristic "fish-scale"-like sevelamer hydrochloride crystals within the mucosa.
CONCLUSIONS: Whether the sevelamer crystals were causal, contributory or purely incidental remains to be clearly elucidated. However, our case raises sufficient concern to warrant additional investigation into whether there is a causal relationship between sevelamer use and intestinal mucosal injury.

Entities:  

Keywords:  Chronic kidney disease; Crystal; Gastrointestinal toxicity; Hyperphosphatemia; Sevelamer carbonate; Sevelamer hydrochloride

Mesh:

Substances:

Year:  2015        PMID: 26563116     DOI: 10.1007/s00467-015-3269-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  Lower gastrointestinal bleeding: association with Sevelamer use.

Authors:  Pankaj Madan; Suverta Bhayana; Prakash Chandra; John I Hughes
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

2.  Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.

Authors:  Nan Chen; Xiongfei Wu; Xiaoqiang Ding; Changlin Mei; Ping Fu; Gengru Jiang; Xuemei Li; Jianghua Chen; Bicheng Liu; Yan La; Fanfan Hou; Zhaohui Ni; Junzhou Fu; Changying Xing; Xuequing Yu; Chaoxing Huang; Li Zuo; Li Wang; John Hunter; Maureen Dillon; Melissa Plone; John Neylan
Journal:  Nephrol Dial Transplant       Date:  2013-10-22       Impact factor: 5.992

Review 3.  Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease.

Authors:  Caroline M Perry; Greg L Plosker
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

4.  Efficacy of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients.

Authors:  Youichi Iwasaki; Hiroya Takami; Masahide Tani; Yoshiyuki Yamaguchi; Hiromichi Goto; Yoshikazu Goto; Yoshiaki Goto; Takashi Shigematsu
Journal:  Ther Apher Dial       Date:  2005-08       Impact factor: 1.762

5.  Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury.

Authors:  Benjamin J Swanson; Berkeley N Limketkai; Ta-Chiang Liu; Elizabeth Montgomery; Kamran Nazari; Jason Y Park; William C Santangelo; Michael S Torbenson; Lysandra Voltaggio; Martha M Yearsley; Christina A Arnold
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

6.  Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease.

Authors:  Sankar D Navaneethan; Ankit Sakhuja; Susana Arrigain; John Sharp; Jesse D Schold; Joseph V Nally
Journal:  Clin Nephrol       Date:  2014-07       Impact factor: 0.975

7.  New Conclusions Regarding Comparison of Sevelamer and Calcium-Based Phosphate Binders in Coronary-Artery Calcification for Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Caixia Wang; Xun Liu; Yongming Zhou; Shaomin Li; Yanbing Chen; Yanni Wang; Tanqi Lou
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 8.  Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.

Authors:  Anjay Rastogi
Journal:  Ther Adv Cardiovasc Dis       Date:  2013-12

9.  Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients.

Authors:  Jia-Feng Chang; Ying-Feng Feng; Yu-Sen Peng; Shih-Ping Hsu; Mei-Fen Pai; Hung-Yuan Chen; Hon-Yen Wu; Ju-Yeh Yang
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

  9 in total
  4 in total

1.  Upper Gastrointestinal Bleeding of Unusual Causation.

Authors:  Chinemerem J Okwara; Rishabh Gulati; Tarun Rustagi; Aleksandr Birg; Joshua Hanson; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2018-10       Impact factor: 3.199

2.  Colonic Mass Secondary to Sevelamer-Associated Mucosal Injury.

Authors:  Vishant Bansal; Pankaj Aggarwal; Akaash Mittal; Meera Vachhani; Prachi Aggarwal; Nitin Aggarwal
Journal:  ACG Case Rep J       Date:  2017-08-02

Review 3.  Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.

Authors:  Solène M Laville; Ziad A Massy; Said Kamel; Jean Marc Chillon; Gabriel Choukroun; Sophie Liabeuf
Journal:  Toxins (Basel)       Date:  2021-01-26       Impact factor: 4.546

4.  Gastrointestinal complications induced by sevelamer crystals.

Authors:  Claudia Yuste; Evangelina Mérida; Eduardo Hernández; Ana García-Santiago; Yolanda Rodríguez; Teresa Muñoz; Gonzalo Jesús Gómez; Ángel Sevillano; Manuel Praga
Journal:  Clin Kidney J       Date:  2017-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.